BRIEF-Oryzon Announces First Patient Dosed In Nci-Sponsored Phase I/Ii Clinical Trial Of Iadademstat Plus Immune Checkpoint Inhibitors In 1L Extensive Stage Small Cell Lung Cancer

Reuters · 6d ago

Please log in to view news